Evidence map›Paper›PMID 26034905›Full record

ArticleScientific reports2015

TFH cells accumulate in mucosal tissues of humanized-DRAG mice and are highly permissive to HIV-1.

Atef Allam, Sai Majji, Kristina Peachman, Linda Jagodzinski, Jiae Kim, Silvia Ratto-Kim, Wathsala Wijayalath, Melanie Merbah, Jerome H Kim, Nelson L Michael and 3 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 53 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Atef Allam1] US Military HIV Research Program, Walter Reed Army Institute of Research [2] Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, Maryland, USA.
Sai MajjiUS Military Malaria Vaccine Program, Naval Medical Research Center, Silver Spring, Maryland, USA.
Kristina Peachman1] US Military HIV Research Program, Walter Reed Army Institute of Research [2] Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, Maryland, USA.
Linda JagodzinskiUS Military HIV Research Program, Walter Reed Army Institute of Research.
Jiae Kim1] US Military HIV Research Program, Walter Reed Army Institute of Research [2] Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, Maryland, USA.
Silvia Ratto-Kim1] US Military HIV Research Program, Walter Reed Army Institute of Research [2] Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, Maryland, USA.
Wathsala WijayalathUS Military Malaria Vaccine Program, Naval Medical Research Center, Silver Spring, Maryland, USA.
Melanie Merbah1] US Military HIV Research Program, Walter Reed Army Institute of Research [2] Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, Maryland, USA.
Jerome H KimUS Military HIV Research Program, Walter Reed Army Institute of Research.
Nelson L MichaelUS Military HIV Research Program, Walter Reed Army Institute of Research.
Carl R AlvingUS Military HIV Research Program, Walter Reed Army Institute of Research.
Sofia CasaresUS Military Malaria Vaccine Program, Naval Medical Research Center, Silver Spring, Maryland, USA.
Mangala RaoUS Military HIV Research Program, Walter Reed Army Institute of Research.
Walter Reed Army Institute of Research · USNaval Medical Research Command · US

Funding

Potent Phage T4 Derived V2 Immunogens as HIV VaccinesR01AI102725 · NIAID · CATHOLIC UNIVERSITY OF AMERICA · PI RAO, VENIGALLA B. · 2012 to 2015
$1.7M
NIAID NIH HHS AI102725NIAID NIH HHS R01 AI102725
6 · The paper itself

Abstract

CD4(+) T follicular helper cells (TFH) in germinal centers are required for maturation of B-cells. While the role of TFH-cells has been studied in blood and lymph nodes of HIV-1 infected individuals, its role in the mucosal tissues has not been investigated. We show that the gut and female reproductive tract (FRT) of humanized DRAG mice have a high level of human lymphocytes and a high frequency of TFH (CXCR5(+)PD-1(++)) and precursor-TFH (CXCR5(+)PD-1(+)) cells. The majority of TFH-cells expressed CCR5 and CXCR3 and are the most permissive to HIV-1 infection. A single low-dose intravaginal HIV-1 challenge of humanized DRAG mice results in 100% infectivity with accumulation of TFH-cells mainly in the Peyer's patches and FRT. The novel finding of TFH-cells in the FRT may contribute to the high susceptibility of DRAG mice to HIV-1 infection. This mouse model thus provides new opportunities to study TFH-cells and to evaluate HIV-1 vaccines.

Indexed as

AnimalsAntigens, SurfaceB-Lymphocyte SubsetsDisease Models, AnimalDisease SusceptibilityFemaleHIV-1HIV InfectionsHumansImmunophenotypingInducible T-Cell Co-Stimulator ProteinInterleukin-21InterleukinsLeukocyte Common AntigensLymphoid TissueMiceAntigens, SurfaceInducible T-Cell Co-Stimulator ProteinInterleukin-21InterleukinsLeukocyte Common AntigensProto-Oncogene Proteins c-bcl-6Receptors, CCR5Receptors, CXCR3

Identifiers

PMID26034905
PMCPMC4451806
OpenAlexW2261436934

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.